REIDER PAUL (Chief Commercial Officer) reported 1 transaction at COHERUS ONCOLOGY, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/7/2025ACC: 0001610717-25-000007
Officer· Chief Commercial Officer
Since Mar 2023
+157.72K
Net shares
Net buyer
$3.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
160K acquired · 2.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.28K
Price / share
$1.66
Trade value
$3.78K
% of position
2.6%
1/4/2025
89.20K→86.93K
Total
Net shares
−2.28K
Net value
-$3.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/4/2025 | F · Tax Withholding | −2.28K | $1.66 | $3.78K | 2.6% | 89.20K | 86.93K |
| Total | −2.28K | -$3.78K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
160K shares
Shares
+160K
Strike price
1.66
Held after
160K
Exercisable
—
1/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock160K shares | 1/3/2025 | A · Award | +160K | 1.66 | — | 160K |